检测骨转移的Al18F-NOTA-HER2-BCH与18F-FDG PET/CT:灵敏度和定量比较
Xiaoyi Guo1, Jiayue Liu1, Huan Ma1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine.
Clinical nuclear medicine
|December 31, 2025
概括
与18F-FDG PET/CT相比,Al18F-NOTA-HER2-BCH PET/CT在HER2阳性乳腺癌中显示出优异的骨转移检测. 这种新型药物对于检测小病变和早期病变特别有效.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 放射学 放射学是一门学科.
背景情况:
- HER2阳性乳腺癌经常转移到骨.
- 准确检测骨转移对于治疗计划和预后至关重要.
- 18F-FDG PET/CT是一种标准的成像方式,但其对骨转移的敏感性可能有限.
研究的目的:
- 为了比较Al18F-NOTA-HER2-BCH PET/CT和18F-FDG PET/CT的诊断性能.
- 评估HER2阳性乳腺癌患者骨和内脏转移的检测率.
主要方法:
- 64名HER2阳性乳腺癌患者的回顾性分析.
- 对18F-NOTA-HER2-BCH PET/CT和18F-FDG PET/CT成像进行比较.
- 由两个独立的读者进行损伤评估,用SUVmax和TBR量化吸收.
主要成果:
- 与18F-FDG PET/CT (87.0%和93.8%) 相比,Al18F-NOTA-HER2-BCH PET/CT对骨转移具有更高的敏感性 (100.0%) 和准确性 (96.9%).
- 通过Al18F-NOTA-HER2-BCH实现了骨质质,骨解质和CT隐形骨损伤的完整检测.
- Al18F-NOTA-HER2-BCH检测到显著更多的亚厘米骨转移,并显示了早期内脏转移识别的潜力.
结论:
- Al18F-NOTA-HER2-BCH PET/CT提供了在HER2阳性乳腺癌中优异的骨转移的检测.
- 这种药物对于识别早期,CT隐形和小骨损伤特别有价值.
- Al18F-NOTA-HER2-BCH PET/CT可能会改善同时发生的内脏转移的检测.
更多相关视频
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
7.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
